New drug combo offers hope for less aggressive blood cancer
NCT ID NCT02682641
Summary
This study is testing whether a combination of two targeted drugs, ibrutinib and rituximab, can effectively control a slower-growing form of mantle cell lymphoma without using traditional chemotherapy. It is for 50 adults who have been diagnosed but have not yet started any treatment and have minimal or no symptoms. The main goal is to see how many patients achieve a complete remission after one year of this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hospital Clínico de Valencia
Valencia, Valencia, Spain
-
Hospital Costa del Sol
Marbella, Málaga, Spain
-
Hospital General Universitario Santa Lucía
Cartagena, Murcia, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Madrid, 28041, Spain
-
Hospital Universitario Clinico de Salamanca
Salamanca, Spain
-
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain
-
Hospital Universitario Mútua Terrassa
Terrassa, Barcelona, Spain
-
Hospital Universitario Ramon y Cajal
Madrid, Madrid, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, Barcelona, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Sevilla, Spain
-
Hospital Universitario de Burgos
Burgos, Burgos, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
-
Institut Català d'Oncologia
Barcelona, Barcelona, Spain
-
MD Anderson Cancer Center
Madrid, Madrid, Spain
Conditions
Explore the condition pages connected to this study.